Deutsch English Français

Contact

EP1077696

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1077696

EP1077696 - FURAN NITRONE THERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 19.04.2002 Database last updated on 20.09.2024
Most recent event Tooltip	19.04.2002	Application deemed to be withdrawn	published on 05.06.2002 [2002/23]
Applicant(s)	For all designated states CENTAUR PHARMACEUTICALS, INC. 484 Oakmead Parkway Sunnyvale, CA 94086 / US
	[2001/09]
Inventor(s)	01 / FLITTER, William, D. 950 High School Way 3230 Mountain View, CA 94041 / US
	02 / GARLAND, William, A. 250 Baldwin Street 901 San Mateo, CA 94401 / US
	03 / GREENWOOD-VAN MEERVELD, Beverly 6224 Kingsbridge Drive Oklahoma City, OK 73162 / US
	04 / IRWIN, Ian 800 Cowper Street Palo Alto, CA 94301 / US
	[2001/09]
Representative(s)	Wibbelmann, Jobst Wuesthoff & Wuesthoff Patentanwälte und Rechtsanwalt PartG mbB Schweigerstrasse 2 81541 München / DE
	[N/P]
Former [2001/09]	Wibbelmann, Jobst, Dr., Dipl.-Chem. Wuesthoff & Wuesthoff, Patent- und Rechtsanwälte, Schweigerstrasse 2 81541 München / DE
Application number, filing date	99922985.9	18.05.1999
	[2001/09]
	WO1999US10444
Priority number, date	US19980085974P	19.05.1998 Original published format: US 85974 P
	[2001/09]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9959579
	Date:	25.11.1999
	Language:	EN
	[1999/47]
	Type:	A1 Application with search report
	No.:	EP1077696
	Date:	28.02.2001
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 25.11.1999 takes the place of the publication of the European patent application.
	[2001/09]
Search report(s)	International search report - published on:	EP	25.11.1999
Classification	IPC:	A61K31/34	[2001/09]
	CPC:	A61K31/351 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/09]
Title	German:	FURAN-NITRONE THERAPEUTISCHE MITTEL ZUR BEHANDLUNG VON ENTZÜNDLICHEN DARMERKRANKUNGEN	[2001/09]
	English:	FURAN NITRONE THERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE	[2001/09]
	French:	MEDICAMENT A BASE DE NITRONE FURANIQUE, DESTINE AU TRAITEMENT DES AFFECTIONS INFLAMMATOIRES DE L'INTESTIN	[2001/09]
Entry into regional phase	09.11.2000	National basic fee paid
	09.11.2000	Designation fee(s) paid
	09.11.2000	Examination fee paid
Examination procedure	17.12.1999	Request for preliminary examination filed International Preliminary Examining Authority: EP
	09.11.2000	Examination requested [2001/09]
	01.12.2001	Application deemed to be withdrawn, date of legal effect [2002/23]
	08.01.2002	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2002/23]
Fees paid	Penalty fee
	Additional fee for renewal fee
	31.05.2001	03 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[PXY]WO9803496 (CENTAUR PHARMACEUTICALS INC ;KELLEHER JUDITH A (US); MAPLES KIRK R) [PX] 1-5,23 * page 2, line 7 * * examples 3-6,8 * * claim - * [PY] 1-23;
		[Y]WO9222290 (OKLAHOMA MED RES FOUND ;UNIV KENTUCKY RES FOUND (US)) [Y] 1-23 * page 8, line 1 - page 12, line L * * See N-oxide compounds disclosed in pages 15-18 * * page 28, lines 6-34 * * claims 1,6,7,11,17,18 *;
		[Y]US5036097 (FLOYD ROBERT A ET AL) [Y] 1-23 * column 3, lines 35-38 *;
		[A]GB1105007 (DAINIPPON PHARMACEUTICAL CO.) [A] 1-23 * the whole document *;
		[A]WO9511227 (OKLAHOMA MED RES FOUND) [A] 1-23 * examples 4-6 *;
		[A]WO9517876 (UNIV KENTUCKY RES FOUND ;CARNEY JOHN M (US); OKLAHOMA MED RES FOUN) [A] 1-23 * claims 1-4 *
		[A] - KIM, H. K. ET AL, "Nitrones. I..alpha.-(5-Nitro-2- furyl )-N- arylnitrones", J. MED. CHEM. (1969), 12, 719-20, XP002111029 [A] 1-23 * the whole document * DOI: http://dx.doi.org/10.1021/jm00304a049
		[A] - BONNER G F, "CURRENT MEDICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE", SOUTHERN MEDICAL JOURNAL, (19960601), vol. 89, no. 6, ISSN 0038-4348, pages 556 - 566, XP000673623 [A] 1-23 * the whole document *
		[A] - ANANA, RAYMOND D. ET AL, "Synthesis and smooth -muscle calcium-channel effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrone moiety in the 4-aryl substituent", ARCH. PHARM. (WEINHEIM, GER.) (1997), 330(3), 53-58, XP002111030 [A] 1-23 * the whole document *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p